Ecuador approves Oxford-AstraZeneca COVID-19 vaccine for emergency use


By EElena

QUITO, Jan. 24 (Xinhua) -- Ecuador's National Agency for Health Regulation, Control, and Surveillance has approved the emergency use of the Oxford-AstraZeneca vaccine against COVID-19, the Ministry of Public Health reported on Sunday.

The Oxford-AstraZeneca vaccine is the second to gain approval for use in Ecuador, after the Pfizer-BioNTech vaccine.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Others Also Read